Reklaim Ltd Renews Normal Course Issuer Bid to Repurchase Up to 10% of Public Float

Rhea-AI Summary

Reklaim (TSXV: MYID / OTC: MYIDF) renewed a Normal Course Issuer Bid to repurchase up to 13,053,580 common shares, equal to 10% of its public float of 130,535,809 shares. The NCIB runs from Feb 17, 2026 to Feb 11, 2027 (or earlier if the maximum is reached).

Purchases will be made on the TSX Venture Exchange at market prices via Integral Wealth Securities Limited, and all acquired shares will be cancelled. Reklaim said the program reflects confidence in its consumer data privacy and monetization platform and offers a non-dilutive capital allocation option. Prior 12-month activity: 209,000 shares repurchased at approximately $0.09–$0.097 per share.

Positive

• NCIB authorizes repurchase of 13,053,580 shares (10% of public float)
• NCIB period: Feb 17, 2026 through Feb 11, 2027 (or earlier if max reached)
• Repurchases executed on TSXV through Integral Wealth Securities Limited
• All repurchased shares will be cancelled, reducing public float if fully executed
• Company cites ability to use cash flow for repurchases rather than dilutive capital

Negative

• No maximum dollar amount or weekly purchase limits disclosed in the NCIB notice
• Repurchase program may reduce cash available for alternative uses or growth investments
• Previous 12-month buybacks totaled only 209,000 shares, suggesting limited recent repurchase scale

News Market Reaction – MYIDF

+3.57%

+3.57% Session move

In the trading session that priced this news, MYIDF gained 3.57%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Share NCIB repurchase program reflects confidence in Reklaim's consumer data privacy and monetization business

TORONTO, Feb. 11, 2026 /PRNewswire/ - Reklaim Ltd. (TSXV: MYID) (OTC: MYIDF) ("Reklaim" or the "Company"), a consumer data privacy and data monetization platform, today announced that the TSX Venture Exchange (the "Exchange") has accepted its notice of intention to renew its Normal Course Issuer Bid ("NCIB").

Under the renewed NCIB, Reklaim may purchase for cancellation up to 13,053,580 common shares, representing 10% of its public float of 130,535,809 issued and outstanding common shares as of the date of the notice.

The NCIB will commence on February 17, 2026 and will terminate on the earlier of February 11, 2027, or the date on which the Company has acquired the maximum number of shares permitted under the NCIB.

Purchases will be made through the facilities of the TSX Venture Exchange at prevailing market prices, in accordance with Exchange policies. The Company has engaged Integral Wealth Securities Limited to conduct purchases on its behalf. All shares acquired under the NCIB will be cancelled.

Rationale for the NCIB

Reklaim believes the current market price of its shares may not fully reflect the intrinsic value of its consumer data privacy platform, proprietary data assets, and future growth opportunities.

Reklaim currently has the flexibility to allocate a portion of its cash flow toward share repurchases rather than raising dilutive capital. The Company views the NCIB as a prudent capital allocation tool when market conditions do not reflect the underlying value of its business.

Previous NCIB Activity

Over the past 12 months, Reklaim repurchased and cancelled a total of 209,000 common shares at prices ranging from approximately $0.09 to $0.097 per share.

About Reklaim Ltd.

Reklaim is a consumer data privacy and data monetization platform that enables individuals to view, control, delete, or monetize their personal data. Reklaim delivers privacy-compliant, consent-based data solutions to brands, agencies, and data partners while empowering consumers with transparency and control over their digital footprint.

For more information, visit:
https://www.reklaimyou.com/investors

Forward-Looking Statements

This news release contains forward-looking statements relating to the Company's NCIB, capital allocation strategy, and future growth. Forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially. Readers are cautioned not to place undue reliance on forward-looking statements. The Company undertakes no obligation to update these statements except as required by law.

Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

View original content to download multimedia:https://www.prnewswire.com/news-releases/reklaim-ltd-renews-normal-course-issuer-bid-to-repurchase-up-to-10-of-public-float-302685232.html

SOURCE Reklaim Ltd.

FAQ

What does Reklaim's NCIB for MYIDF authorize and how many shares can be repurchased?

The NCIB authorizes repurchase of up to 13,053,580 common shares, equal to 10% of the public float. According to the company, that figure is based on a public float of 130,535,809 issued and outstanding common shares as of the notice date.

When does the Reklaim (MYIDF) share buyback start and when will it end?

The NCIB commences on Feb 17, 2026 and terminates on Feb 11, 2027 or earlier if the maximum is acquired. According to the company, purchases stop once the maximum permitted shares are bought.

How will Reklaim (MYIDF) execute repurchases under the NCIB?

Repurchases will be made on the TSX Venture Exchange at prevailing market prices through Integral Wealth Securities Limited. According to the company, all purchases follow Exchange policies and purchased shares will be cancelled.

What prior buyback activity has Reklaim (MYIDF) completed in the past 12 months?

Over the past 12 months Reklaim repurchased and cancelled 209,000 common shares. According to the company, those purchases occurred at prices of approximately $0.09 to $0.097 per share.

How might Reklaim's NCIB affect shareholders and company cash?

The NCIB could increase shareholder value per share if repurchases reduce float, but it uses company cash. According to the company, it sees buybacks as a non-dilutive allocation option when market prices do not reflect intrinsic value.